356 related articles for article (PubMed ID: 33220906)
1. Is Breast Implant-Associated Anaplastic Large Cell Lymphoma Better Classified as a Lymphoproliferative Disorder and How Surgeons Reduce Risk?
Lukavsky RJ; Couto RA; Adams WP
Clin Plast Surg; 2021 Jan; 48(1):71-77. PubMed ID: 33220906
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and Treatment of Advanced Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Collins MS; Miranda RN; Medeiros LJ; Silva de Meneses MP; Iyer SP; Butler CE; Liu J; Clemens MW
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):41S-50S. PubMed ID: 30817555
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic Large-Cell Lymphoma Associated with Breast Implants: A Case Report of a Transgender Female.
Patzelt M; Zarubova L; Klener P; Barta J; Benkova K; Brandejsova A; Trneny M; Gürlich R; Sukop A
Aesthetic Plast Surg; 2018 Apr; 42(2):451-455. PubMed ID: 29101436
[TBL] [Abstract][Full Text] [Related]
4. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery?
Fitzal F; Turner SD; Kenner L
Open Biol; 2019 Apr; 9(4):190006. PubMed ID: 30939983
[TBL] [Abstract][Full Text] [Related]
5. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
O'Connell RL; Sharma B; El-Sharkawi D; Wotherspoon A; Attygalle AD; MacNeill F; Khan AA; Tasoulis MK
Ann Surg Oncol; 2023 Oct; 30(10):6170-6175. PubMed ID: 37454017
[TBL] [Abstract][Full Text] [Related]
6. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
[TBL] [Abstract][Full Text] [Related]
7. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
[TBL] [Abstract][Full Text] [Related]
8. Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Blombery P; Thompson ER; Prince HM
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S-64S. PubMed ID: 30817557
[TBL] [Abstract][Full Text] [Related]
9. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.
Collett DJ; Rakhorst H; Lennox P; Magnusson M; Cooter R; Deva AK
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. PubMed ID: 30817554
[TBL] [Abstract][Full Text] [Related]
10. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
Kadin ME; Adams WP; Inghirami G; Di Napoli A
Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
[TBL] [Abstract][Full Text] [Related]
11. [Thirty-six (36) French cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): What do we know about their prosthetic histories, and what conclusions may be drawn?].
Ruffenach L; Bruant-Rodier C; Goldammer F; Ramelli E; Bodin F; Dissaux C
Ann Chir Plast Esthet; 2019 Aug; 64(4):285-292. PubMed ID: 31331683
[TBL] [Abstract][Full Text] [Related]
12. Breast Implant-associated Anaplastic Large Cell Lymphoma.
Alotaibi S; Hamadani M; Al-Mansour M; Aljurf M
Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e272-e276. PubMed ID: 33384263
[TBL] [Abstract][Full Text] [Related]
13. Is Banning Texturized Implants to Prevent Breast Implant-Associated Anaplastic Large Cell Lymphoma a Rational Decision? A Meta-Analysis and Cost-Effectiveness Study.
Danilla SV; Jara RP; Miranda F; Bencina F; Aguirre M; Troncoso E; Erazo CA; Andrades PR; Sepulveda SL; Albornoz CR
Aesthet Surg J; 2020 Jun; 40(7):721-731. PubMed ID: 31761953
[TBL] [Abstract][Full Text] [Related]
14. Public Perceptions on Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Lee E; Khavanin N; He W; Darrach H; Kraenzlin F; Jenny H; Yang R; Sacks JM
Plast Reconstr Surg; 2020 Jul; 146(1):30-37. PubMed ID: 32590638
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Deva A; Xu H; Morgan J; Khare P; MacLeod RA; Van Natta BW; Adams WP; Brody GS; Epstein AL
Aesthet Surg J; 2016 Jul; 36(7):773-81. PubMed ID: 26979456
[TBL] [Abstract][Full Text] [Related]
16. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
[TBL] [Abstract][Full Text] [Related]
17. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Defining Future Research Priorities.
DeCoster RC; Lynch EB; Bonaroti AR; Miranda RN; Hunt KK; Clemens MW
Clin Plast Surg; 2021 Jan; 48(1):33-43. PubMed ID: 33220903
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
Fleming D; Stone J; Tansley P
Aesthetic Plast Surg; 2018 Jun; 42(3):672-678. PubMed ID: 29445921
[TBL] [Abstract][Full Text] [Related]
19. The Influence of BIA-ALCL on the Use of Textured Breast Implant and its Placement: A Survey of Dutch Plastic Surgeons.
Bletsis PP; van Veen MM; van der Lei B
Aesthet Surg J; 2023 Jul; 43(8):NP595-NP601. PubMed ID: 36929763
[TBL] [Abstract][Full Text] [Related]
20. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
